LONDON, England—Patients with stable coronary artery disease and severe aortic stenosis fare significantly better over the long term if revascularized with PCI before TAVI than if they are treated ...
LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the ...
In the RHEIA trial, TAVI outperformed surgery in composite outcome of death, stroke, or rehospitalization in all-comer women with severe aortic stenosis.
LONDON, England—If operators choose to continue a patient’s oral anticoagulation during TAVI, they are likely increasing bleeding without getting a benefit in the form of fewer thromboembolic events, ...
At the European Society of Cardiology Congress 2024, Edwards Lifesciences EW announced the results from the RHEIA Trial — the first-ever study focused exclusively on women receiving transcatheter ...